|
ALS2CR4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.17230000046465E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.91040000485643E-08 |
| Normal-vs-Stage2 |
3.50850000000458E-05 |
| Normal-vs-Stage3 |
1.823560E-01 |
| Normal-vs-Stage4 |
6.982300E-02 |
| Stage1-vs-Stage2 |
5.495800E-01 |
| Stage1-vs-Stage3 |
9.011000E-04 |
| Stage1-vs-Stage4 |
2.982200E-01 |
| Stage2-vs-Stage3 |
4.678400E-02 |
| Stage2-vs-Stage4 |
5.727600E-01 |
| Stage3-vs-Stage4 |
3.830400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.59659999665607E-08 |
| Normal-vs-AfricanAmerican |
2.01579999999923E-05 |
| Normal-vs-Asian |
1.115960E-01 |
| Caucasian-vs-AfricanAmerican |
4.151800E-01 |
| Caucasian-vs-Asian |
3.542200E-01 |
| AfricanAmerican-vs-Asian |
5.330000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.75204295516096E-12 |
| Normal-vs-Female |
1.194990E-01 |
| Male-vs-Female |
2.87889999994739E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.11420000000495E-05 |
| Normal-vs-Extreme_Weight |
3.17819992545765E-10 |
| Normal-vs-Obese |
2.33799999999063E-05 |
| Normal-vs-Extreme_Obese |
3.74899999999734E-05 |
| Normal_Weight-vs-Extreme_Weight |
9.471700E-02 |
| Normal_Weight-vs-Obese |
7.629800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.379800E-01 |
| Extreme_Weight-vs-Obese |
4.203700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.152400E-01 |
| Obese-vs-Extreme_Obese |
2.911800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.135600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.5624000000436E-06 |
| Normal-vs-Age(61-80Yrs) |
1.44919998223969E-09 |
| Normal-vs-Age(81-100Yrs) |
3.241600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.345800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.412400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.550000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.604200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.534200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.314200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.50020012973573E-12 |
| Normal-VS-Type2 PRCC |
4.733199999718E-07 |
| Normal-VS-KIRP CIMP |
2.571800E-01 |
| Normal-VS-Unclassified PRCC |
2.102400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.067610E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.135300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.780500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.067570E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.115800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.846110E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.2762999546112E-09 |
| Normal-vs-N1 |
7.685400E-01 |
| Normal-vs-N2 |
1.519200E-01 |
| N0-vs-N1 |
1.020870E-03 |
| N0-vs-N2 |
1.460560E-01 |
| N1-vs-N2 |
4.227400E-01 |
|
|
